The findings from this study highlight the significant role that immune markers, such as FOXP3, PD-1, and CD32B, play in the tumor microenvironment (TME) of lung adenocarcinoma, providing valuable insights into their potential as prognostic biomarkers and therapeutic targets. The gene discussed is FOXP3; the disease is lung adenocarcinoma.